Cargando...
Understanding PD-L1 Testing in Breast Cancer: A Practical Approach
BACKGROUND: Immune checkpoint inhibitors (ICI) have changed therapy strategies for cancer patients tremendously. Some approved ICI acquire testing of PD-L1 expression on tumor and/or immune cells. However, since PD-L1 testing is a comprehensive issue with various assays, antibody clones, scoring met...
Guardado en:
| Publicado en: | Breast Care (Basel) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger GmbH
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650134/ https://ncbi.nlm.nih.gov/pubmed/33223991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510812 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|